These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9489083)

  • 21. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
    Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
    J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Losartan with hydrochlorothiazide in the treatment of hypertension.
    Schoenberger JA;
    J Hypertens Suppl; 1995 Jul; 13(1):S43-7. PubMed ID: 18800455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK; Fischer HM; Pittrow D; Bohlscheid V
    Fortschr Med Orig; 2003; 121(1):27-32. PubMed ID: 15117066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial.
    Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS
    Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study to investigate the comparative efficacy and tolerability of nisoldipine coat-core and atenolol in the treatment of mild to moderate hypertension.
    Murray TS
    Br J Clin Pract; 1996; 50(7):368-72. PubMed ID: 9015908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
    Galzerano D; Tammaro P; Cerciello A; Breglio R; Mallardo M; Lama D; Tuccillo B; Capogrosso P
    J Hum Hypertens; 2004 Jan; 18(1):53-9. PubMed ID: 14688811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Double blind comparative randomized study of the efficacy of celiprolol versus amiloride-hydrochlorothiazide in mild to moderate AHT].
    Oliván Martínez J; Hoyos Jiménez M; Miranda García MJ; Justo Alpañés E; Pérez Cano R
    An Med Interna; 1993 May; 10(5):221-7. PubMed ID: 8518337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments].
    Santucci A; De Cesaris R; Buoninconti R; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):149-53. PubMed ID: 2678308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different sensitivity to hydrochlorothiazide and to potassium-canrenoate among essential hypertensive patients.
    Glorioso N; Melis MG; Manunta P; Troffa C; Tonolo G; Soro A; Madeddu P; Pazzola A; Pala F; Cusi D
    Clin Exp Hypertens; 1993; 15 Suppl 1():187-96. PubMed ID: 8513309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biochemical changes in hypertensive patients during a 1-year cross-over study of treatment with hydrochlorothiazide and propranolol].
    Bagatin J; Rumboldt Z; Polić S; Sardelić S; Ljutić D; Capkun V; Pivac N; Petrović P; Bojić L
    Lijec Vjesn; 1996; 118(1-2):11-6. PubMed ID: 8759414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study of nisoldipine and alpha-methyldopa in aged patients with isolated systolic hypertension].
    Guillén Llera F; Reuss JM; Sagués F; Tobares N
    Rev Clin Esp; 1991 Dec; 189(9):412-5. PubMed ID: 1792369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association of polymorphism in alpha-adducin gene with antihypertensive effect of Hydrochlorothiazide].
    Wu SL; Li DQ; Li HF; Yu Q; Li Y; Zhao HY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Oct; 33(10):880-4. PubMed ID: 16266470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
    Ruddy TD; Fodor JG
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.
    Chamiec T; Bednarz B; Budaj A; Kłoś J; Pietrzykowska H; Zaleska T; Ceremuzyński L
    Mater Med Pol; 1990; 22(3):188-90. PubMed ID: 2132424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in indian patients with mild-to-moderate essential hypertension.
    Pareek A; Zawar SD; Salagre SB; Chandurkar NB; Karnik ND
    Eur J Med Res; 2009 Jul; 14(7):297-303. PubMed ID: 19661012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.